Spurred by revenue growth from new hospitals and higher pharmacy income, Apollo Hospitals recorded a 71 per cent increase in net profit at ₹60 crore for the quarter ended June 2018 as against ₹35 crore in the same period last year, according to a company release.
“We continue to strengthen our healthcare portfolio to benefit our patients and arm our doctors with the latest in artificial intelligence and medical technology,” said Prathap C Reddy, Chairman, Apollo Hospitals.
Standalone revenue from operations rose 16 per cent to ₹1,910 crore (₹1,650 crore). Revenue from operations was aided by a 20 per cent growth in standalone pharmacies and 12 per cent growth in healthcare services on a year-on-year basis.
The growth in healthcare services was led by new hospitals which contributed 23 per cent of the revenue (₹212 crore) while the existing hospitals’ revenue improved 10 per cent YoY. The company’s EBITDA improved by 31 per cent to ₹227 crore (₹173 crore).
In June 2018, the company acquired a 50 per cent stake in Lucknow-based Medics International Lifesciences Ltd, Limited, a 330-bed super-specialty hospital, for ₹91 crore, the release said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.